Abstract

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 546

Download in electronic PDF format for $75

Abstract

A formulation for preparing Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Nov/Dec 2008 Pg. 547	Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 545	Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 548	Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2012 Pg. 376-380	Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Author(s): Snyder Scott, Listecki Robert E
Jan/Feb 2024 Pg. 34-43	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Nov/Dec 2008 Pg. 488-497	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Jul/Aug 2005 Pg. 268-273	Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Author(s): Milner Martin
Jul/Aug 2010 Pg. 306-309	Thyroid Potency Calculations Author(s): Stack Bob
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
Nov/Dec 2013 Pg. 505	Levothyroxine Sodium 100-mcg Capsules Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 193-199	The Role of Sex Hormones on Fibromyalgia Pain Mediators Author(s): Bramwell Bethany L
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr